+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Microrna"

Cell Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Cell Therapy - Technologies, Markets and Companies

  • Report
  • November 2021
  • 1184 Pages
  • Global
From
Precision Medicine in Oncology. Edition No. 1 - Product Thumbnail Image

Precision Medicine in Oncology. Edition No. 1

  • Book
  • October 2020
  • 288 Pages
Toxicology and Epigenetics. Edition No. 1 - Product Thumbnail Image

Toxicology and Epigenetics. Edition No. 1

  • Book
  • September 2012
  • 688 Pages
MicroRNA. From Bench to Bedside - Product Thumbnail Image

MicroRNA. From Bench to Bedside

  • Book
  • July 2022
Loading Indicator

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools. Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more